This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
n6http://dbpedia.org/resource/File:
foafhttp://xmlns.com/foaf/0.1/
n17https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
n4http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Neuraminidase_inhibitor
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_neuraminidase_inhibitors
Subject Item
dbr:Discovery_and_development_of_neuraminidase_inhibitors
rdfs:label
Discovery and development of neuraminidase inhibitors
rdfs:comment
Neuraminidase inhibitors inhibit enzymatic activity of the enzyme neuraminidase (sialidase). These type of inhibitors have been introduced as anti-influenza drugs as they prevent the virus from exiting infected cells and thus stop further spreading of the virus. Neuraminidase inhibitors for human neuraminidase (hNEU) have the potential to be useful drugs as the enzyme plays a role in several signaling pathways in cells and is implicated in diseases such as diabetes and cancer.
foaf:depiction
n4:Beta_N-Acetylneuraminic_Acid.svg n4:Mechanism_of_action.png n4:Peramivir.svg n4:Prodrug_of_laninamivir.png n4:Benzoic_acid_analogue.png n4:Paramivir_analogue.png n4:Phophono-zanamivir.png n4:Phosphonate_analogue.png n4:Machanism_of_Neuraminidase_inhibitor.png n4:C4_analogue_of_zanamivir.png n4:Trizole-containing_carbocycles_analogue.png n4:N-acetylneuraminic_acid_(Neu5Ac).png n4:Laninamivir.svg n4:4-aminopho_phono-DANA.png n4:Zanamivir_structure.svg n4:Oseltamivir.svg
dcterms:subject
dbc:Drug_discovery dbc:Neuraminidase_inhibitors
dbo:wikiPageID
44298290
dbo:wikiPageRevisionID
1107868036
dbo:wikiPageWikiLink
dbr:Enzyme_inhibitor dbr:Influenza n6:Paramivir_analogue.png dbr:Click_chemistry n6:Machanism_of_Neuraminidase_inhibitor.png dbr:Methoxy n6:Zanamivir_structure.svg dbr:Influenza_virus n6:Oseltamivir.svg dbr:Zanamivir n6:Prodrug_of_laninamivir.png dbr:Adamantane dbr:Cancer dbr:Signaling_pathways n6:Mechanism_of_action.png dbr:X-ray_crystallography dbr:Hydroxyl dbr:Neuraminidase_inhibitor dbr:Organic_synthesis dbr:Pyrrolidine dbr:Esterase dbr:Neuraminidase n6:Phophono-zanamivir.png n6:Phosphonate_analogue.png n6:C4_analogue_of_zanamivir.png n6:Benzoic_acid_analogue.png dbr:Virions n6:Beta_N-Acetylneuraminic_Acid.svg dbr:N-acetylneuraminic_acid dbr:Aglycon dbr:Isoenzyme dbr:Mucin dbr:Enzyme_catalysis n6:N-acetylneuraminic_acid_(Neu5Ac).png dbc:Drug_discovery dbr:Laninamivir dbr:Beta_propeller dbr:Oseltamivir dbr:Epithelial_cells dbr:Phosphonate dbr:Benzene n6:4-aminopho_phono-DANA.png dbr:Tyrosine n6:Trizole-containing_carbocycles_analogue.png dbr:Glycoproteins dbr:Monosaccharide dbr:Beta_sheet dbr:Bioavailability dbr:Carboxylate n6:Laninamivir.svg dbr:Exoglycosidase dbr:Ethyl_group dbr:Cyclopentane dbc:Neuraminidase_inhibitors dbr:Hemagglutinin dbr:Neuraminidase_inhibitors dbr:Gangliosides dbr:Sialic_acid dbr:Diabetes dbr:Topology dbr:Prophylaxis dbr:Peramivir n6:Peramivir.svg
owl:sameAs
wikidata:Q25326519 freebase:m.0127x6nl n17:2PKrh
dbp:wikiPageUsesTemplate
dbt:RNA_antivirals dbt:TOC_limit dbt:Influenza dbt:Drug_design dbt:Enzyme_inhibition
dbo:thumbnail
n4:Beta_N-Acetylneuraminic_Acid.svg?width=300
dbo:abstract
Neuraminidase inhibitors inhibit enzymatic activity of the enzyme neuraminidase (sialidase). These type of inhibitors have been introduced as anti-influenza drugs as they prevent the virus from exiting infected cells and thus stop further spreading of the virus. Neuraminidase inhibitors for human neuraminidase (hNEU) have the potential to be useful drugs as the enzyme plays a role in several signaling pathways in cells and is implicated in diseases such as diabetes and cancer.
prov:wasDerivedFrom
wikipedia-en:Discovery_and_development_of_neuraminidase_inhibitors?oldid=1107868036&ns=0
dbo:wikiPageLength
30919
foaf:isPrimaryTopicOf
wikipedia-en:Discovery_and_development_of_neuraminidase_inhibitors
Subject Item
dbr:Discovery_and_development_of_Neuraminidase_Inhibitors
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_neuraminidase_inhibitors
dbo:wikiPageRedirects
dbr:Discovery_and_development_of_neuraminidase_inhibitors
Subject Item
dbr:GS_4071
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_neuraminidase_inhibitors
dbo:wikiPageRedirects
dbr:Discovery_and_development_of_neuraminidase_inhibitors
Subject Item
wikipedia-en:Discovery_and_development_of_neuraminidase_inhibitors
foaf:primaryTopic
dbr:Discovery_and_development_of_neuraminidase_inhibitors